Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX)
CUSIP: 03940C100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 100
- Total 13F shares
- 61,569,105
- Share change
- +2,371,228
- Total reported value
- $4,042,657,536
- Put/Call ratio
- 39%
- Price per share
- $65.60
- Number of holders
- 195
- Value change
- +$146,759,811
- Number of buys
- 97
- Number of sells
- 106
Quarterly Holders Quick Answers
What is CUSIP 03940C100?
CUSIP 03940C100 identifies ACLX - Arcellx, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03940C100:
Top shareholders of ACLX - Arcellx, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7956633%
|
7,956,633
|
$610,194,207 | — | 31 Dec 2024 | |
| GILEAD SCIENCES, INC. |
13F
3/4/5
|
Company · 10%+ Owner |
6720803%
|
6,720,803
|
$515,418,382 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
4371601%
|
4,371,601
|
$335,258,081 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.4%
from 13D/G
|
3,854,021
|
$295,564,873 | — | 31 Dec 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
3745262%
|
3,745,262
|
$287,224,143 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3478888%
|
3,478,888
|
$266,795,921 | — | 31 Dec 2024 | |
| NEA Partners 15, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,745,262
|
$262,260,666 | — | 20 Dec 2022 | |
| New Enterprise Associates 15, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,745,262
|
$262,260,666 | — | 20 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3330092%
|
3,330,092
|
$255,384,756 | — | 31 Dec 2024 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,016,878
|
$222,004,412 | — | 08 Feb 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2787327%
|
2,787,327
|
$213,760,108 | — | 31 Dec 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2346630%
|
2,346,630
|
$179,963,055 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2121322%
|
2,121,322
|
$162,685,000 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1775372%
|
1,775,372
|
$136,153,279 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1557092%
|
1,557,092
|
$119,473,748 | — | 31 Dec 2024 | |
| Lewis T. "rusty" Williams |
3/4/5
|
Director |
—
class O/S missing
|
2,095,114
|
$115,792,551 | — | 08 Feb 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1300000%
|
1,300,000
|
$99,697,000 | — | 31 Dec 2024 | |
| SR ONE CAPITAL MANAGEMENT, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,658,780
|
$91,677,287 | — | 11 May 2023 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
1047557%
|
1,047,557
|
$80,337,146 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
979026%
|
979,026
|
$75,097,908 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
974832%
|
974,832
|
$74,760,000 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
705922%
|
705,922
|
$54,138,000 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
618117%
|
618,117
|
$47,403,482 | — | 31 Dec 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
475000%
|
475,000
|
$36,427,750 | — | 31 Dec 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
425000%
|
425,000
|
$32,593,250 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
410733%
|
410,733
|
$31,499,114 | — | 31 Dec 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
348333%
|
348,333
|
$26,713,658 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
344529%
|
344,529
|
$26,421,929 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
343085%
|
343,085
|
$26,311,189 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
305088%
|
305,088
|
$23,399,631 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
290011%
|
290,011
|
$22,240,943 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
269386%
|
269,386
|
$20,659,234 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
267384%
|
267,384
|
$20,505,678 | — | 31 Dec 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
253641%
|
253,641
|
$19,451,728 | — | 31 Dec 2024 | |
| Capital World Investors |
13F
|
Company |
252878%
|
252,878
|
$19,393,214 | — | 31 Dec 2024 | |
| Artia Global Partners LP |
13F
|
Company |
229785%
|
229,785
|
$17,622,212 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
224456%
|
224,456
|
$17,213,529 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
207539%
|
207,539
|
$15,916,166 | — | 31 Dec 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
194996%
|
194,996
|
$14,954,243 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
184183%
|
184,183
|
$14,124,995 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
178198%
|
178,198
|
$13,666,005 | — | 31 Dec 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
163918%
|
163,918
|
$12,570,871 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
156094%
|
156,094
|
$11,970,849 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
154400%
|
154,400
|
$11,840,936 | — | 31 Dec 2024 | |
| First Turn Management, LLC |
13F
|
Company |
152356%
|
152,356
|
$11,684,182 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
148107%
|
148,107
|
$11,358,326 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
144409%
|
144,409
|
$11,074,727 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
136203%
|
136,203
|
$10,445,408 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
134197%
|
134,197
|
$10,291,567 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
130601%
|
130,601
|
$10,015,790 | — | 31 Dec 2024 |
Institutional Holders of Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX) as of Q1 2025
As of 31 Mar 2025,
Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,569,105 shares.
The largest 10 holders included
GILEAD SCIENCES, INC., FMR LLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, BlackRock, Inc., NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Vestal Point Capital, LP, and SR One Capital Management, LP.
This page lists
197
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
208
Q1 2025 holders
195
Holder diff
-13
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.